SPRUCE BIOSCIENCES, INC.

For the period ended Dec 31, 2025. Filed Mar 9, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 9, 2026

SPRB$49.34+6.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Statements of Stockholders’ Equity

(in thousands, except share amounts)

Additional · Total
Common Stock · Paid-In · Accumulated · Stockholders'
Shares · Amount · Capital · Deficit · Equity
Balance as of January 1, 2024	547,019		$—	$273,741	$(197,232)	$76,509
Exercise of common stock options	1,595		—	180	—	180
Issuance of common stock related to employee stock purchase plan	2,107		—	66	—	66
Issuance of common stock related to vesting of restricted stock units, net of tax withholdings	12,321		—	(246)	—	(246)
Stock-based compensation	—		—	5,348	—	5,348
Net loss	—		—	—	(53,036)	(53,036)
Balance as of December 31, 2024	563,042		—	279,089	(250,268)	28,821
Exercise of common stock options	61		—	5	—	5
Issuance of common stock related to employee stock purchase plan	5,485		—	25	—	25
Issuance of common stock related to vesting of restricted stock units, net of tax withholdings	14,175		—	(831)	—	(831)
Issuance of common stock, net of offering costs of $3,400	502,181		—	46,600	—	46,600
Exercise of pre-funded warrants	287,099		—	4,288	—	4,288
Stock-based compensation	—		—	2,574	—	2,574
Net loss	—		—	—	(38,966)	(38,966)
Balance as of December 31, 2025	1,372,043	$	-	$331,750	$(289,234)	$42,516

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.